Thailand — Fishery/Seafood Products

← back to leaderboard

Thailand received 121 FDA import refusals in Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 29 in 2026-Q1, with the trend rising sharply year-on-year. The most-cited issues are filthy, salmonella, and mfr insan. No trade baseline is published for this commodity from Thailand, so no per-$1B rate is shown here.

Of these, 113 were hazard refusals and 8 were paperwork refusals.

Exporting from Thailand? Get an email when shipments from Thailand are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

8 2023-Q4 2023-Q4: 8 6 2024-Q1 2024-Q1: 6 3 2024-Q2 2024-Q2: 3 2 2024-Q3 2024-Q3: 2 5 2024-Q4 2024-Q4: 5 13 2025-Q1 2025-Q1: 13 9 2025-Q2 2025-Q2: 9 8 2025-Q3 2025-Q3: 8 12 2025-Q4 2025-Q4: 12 29 2026-Q1 2026-Q1: 29 12 2026-Q2 2026-Q2: 12 14 2026-Q3 2026-Q3: 14

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Fish-Other 103 filthy
Shrimp-Prawn 13 vetdrugres
Tuna 5 filthy

Recent rejections